Associations of pentraxin 3 with cardiovascular disease and all-cause death: the Cardiovascular Health Study.
about
The inflammatory protein Pentraxin 3 in cardiovascular diseaseDifferential associations of inflammatory and endothelial biomarkers with disease activity in rheumatoid arthritis of short durationAssociations of pentraxin 3 with cardiovascular disease: the Multi-Ethnic Study of AtherosclerosisPentraxin-3 and the right ventricle: the Multi-Ethnic Study of Atherosclerosis-Right Ventricle Study.Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul StudyPentraxin-3 as a marker of advanced atherosclerosis results from the Bruneck, ARMY and ARFY Studies.Influence of pentraxin 3 (PTX3) genetic variants on myocardial infarction risk and PTX3 plasma levels.Elevated plasma pentraxin 3 and its association with retinal vein occlusion.Pentraxin 3 mediates neurogenesis and angiogenesis after cerebral ischaemia.Differential associations of serum amyloid A and pentraxin-3 with allele-specific lipoprotein(a) levels in African Americans and Caucasians.Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis.Plasma pentraxin 3 levels do not predict coronary events but reflect metabolic disorders in patients with coronary artery disease in the CARE trial.Pentraxin 3(PTX 3): an endogenous modulator of the inflammatory responsePentraxin-3 as a marker of disease severity and risk of death in patients with necrotizing soft tissue infections: a nationwide, prospective, observational study.Association between levels of pentraxin 3 and incidence of chronic kidney disease in the elderly.Long pentraxin 3: experimental and clinical relevance in cardiovascular diseasesVascular pentraxin 3 controls arterial thrombosis by targeting collagen and fibrinogen induced platelets aggregation.Lifestyle intervention is associated with decreased concentrations of circulating pentraxin 3 independent of CRP decrease.Emerging families of biomarkers for coronary artery disease: inflammatory mediatorsPentraxin 3 as a Novel Marker in Cardiovascular Diseases?Modification of the secretion pattern of proteases, inflammatory mediators, and extracellular matrix proteins by human aortic valve is key in severe aortic stenosisSynergistic effects of hypertension and aging on cognitive function and hippocampal expression of genes involved in β-amyloid generation and Alzheimer's disease.The acute-phase protein PTX3 is an essential mediator of glial scar formation and resolution of brain edema after ischemic injury.Interesting Correlation Between the Circulating Pentraxin 3 and Cardiac Rehabilitation Program Outcomes in Coronary Artery Bypass Grafting Patients.The time profile of Pentraxin 3 in patients with acute ST-elevation myocardial infarction and stable angina pectoris undergoing percutaneous coronary intervention.The long pentraxin PTX3 at the crossroads between innate immunity and tissue remodelling.Cardiovascular metabolic syndrome: mediators involved in the pathophysiology from obesity to coronary heart disease.The long pentraxin PTX3: a paradigm for humoral pattern recognition molecules.The long pentraxin PTX3: a candidate anti-inflammatory mediator in cardiac surgery.Effects of 6 months of resveratrol versus placebo on pentraxin 3 in patients with type 2 diabetes mellitus: a double-blind randomized controlled trial.Pentraxin 3 and lipid profile status in pregnancy.Pentraxins in the activation and regulation of innate immunity.The effects of high intensity interval training in women with rheumatic disease: a pilot study.Serum Pentraxin-3 Level in Patients Who Underwent Coronary Angiography and Relationship with Coronary Atherosclerosis.Pentraxin 3, ficolin-2 and lectin pathway associated serine protease MASP-3 as early predictors of myocardial infarction - the HUNT2 study.Cigarette smoke induces PTX3 expression in pulmonary veins of mice in an IL-1 dependent manner.Serum pentraxin-3 levels are associated with the severity of metabolic syndromePlasma Pentraxin 3, but not high-sensitivity C-reactive protein, is a useful inflammatory biomarker for predicting cognitive impairment in elderly hypertensive patients.Inflammatory markers of cardiovascular disease risk in Portuguese psoriatic patients: relation with narrow-band ultraviolet B and psoralen plus ultraviolet A.Plasma pentraxin 3 is associated with cardiovascular disease in hemodialysis patients.
P2860
Q26738957-547F13E3-18F3-45F7-9ED1-1418AF3C6DD7Q33593925-75CA2292-3963-4C36-AF48-063F8DF2DA61Q33748025-F9FAF7FE-E24A-46DE-BAC3-42D40A1ABD60Q33805985-06555B98-E7A3-4B76-ACED-EC3F11E4405FQ34150807-D1A6EA53-0960-4746-BF49-24A091F1D3D8Q34154838-3EAEC3EF-8E55-4F86-BBCC-DFD24810B430Q34534979-17ACA79D-E792-469D-8C6F-708F51C639E1Q34551919-A9C1E57F-825B-4E17-8F83-6EEE3B3BBF43Q35021428-CAD8F5D1-3FA6-47FB-9660-FAFCFE3708C3Q35109551-D73301AF-60D9-4FDB-AFF1-79974795F205Q35133148-881680EB-E963-4560-A652-6E4D90041CF9Q35140370-EB4CEFD9-B339-4A98-9F02-689BD6F5D055Q35915482-E6471268-4902-4817-90B5-3E38727CA7E1Q35924554-E85A1609-8868-497D-A0A9-25C8E722D2A3Q36533057-4AE1368E-23B6-4817-9CBD-47946BD73228Q36830914-0F28FBB3-6E67-4B5E-B10D-DAA2C5FCDFD8Q36869842-4EB0ABD7-55A2-4D4C-A8C5-4F61F6916696Q37019061-C7CC9EAA-9561-411B-83D6-E7AA9C2968E0Q37115819-0DA880B6-93A7-4F74-8CE7-C5771EC95A03Q37155352-78F4ECE8-7FCA-4D8D-9175-A97BF1E37CFFQ37160916-451B57AF-B868-43E5-A6B7-0584C08BC736Q37234962-55C26F6D-1EF6-424C-90F7-67A6D3DD28F8Q37627769-F3B00880-1033-46D0-9DED-6CE92F9DB363Q37629231-54941534-C8AB-4240-810E-4BA877C48986Q37668815-FDF4A4C8-E8A0-4031-A06A-31245979EB4CQ37851153-658336C5-688D-4A1F-A576-5A1005A5988AQ37980497-2B2090C9-ADE9-4851-962E-FDE290E51A27Q38092832-94A36CD3-E93D-4931-8223-A4CC2E350A48Q38102657-E2F67FD9-FFF0-4499-81AC-A8D16EC86C75Q38380295-4A6742E7-4A03-4EBD-81E5-5CDDEE56B40BQ38728491-404EB05F-05DE-4D8F-8E06-53F8F9CBCBD2Q38991073-49215429-2905-4853-A6AD-EB88B6EC59B5Q40900237-1A2E589E-ABF3-4B1B-96EB-C15D19FED59AQ41741922-AAFC2BBF-6B82-4B63-AAD9-4A9B5AEB68E3Q41907221-BC26C2E6-78EC-4B07-867E-4EB013256D78Q42407067-3F8AC50B-B3A8-41A1-B6C8-40E77A72C5A6Q42759835-3FAC2833-5953-4E07-9C51-40262E7223FBQ43142703-183D36A5-8452-4EE8-BF9C-950500F5FDCDQ43539555-405C0D7A-34CA-46B8-936E-64CFF6A2AD7AQ44456570-8D504779-E7D2-44C3-A0B9-9185188B9D87
P2860
Associations of pentraxin 3 with cardiovascular disease and all-cause death: the Cardiovascular Health Study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Associations of pentraxin 3 wi ...... e Cardiovascular Health Study.
@en
Associations of pentraxin 3 wi ...... e Cardiovascular Health Study.
@nl
type
label
Associations of pentraxin 3 wi ...... e Cardiovascular Health Study.
@en
Associations of pentraxin 3 wi ...... e Cardiovascular Health Study.
@nl
prefLabel
Associations of pentraxin 3 wi ...... e Cardiovascular Health Study.
@en
Associations of pentraxin 3 wi ...... e Cardiovascular Health Study.
@nl
P2093
P2860
P1476
Associations of pentraxin 3 wi ...... e Cardiovascular Health Study.
@en
P2093
Alice M Arnold
Nancy Swords Jenny
Russell P Tracy
P2860
P304
P356
10.1161/ATVBAHA.108.178947
P407
P577
2009-01-22T00:00:00Z